Patient Guide: A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 13 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06630806
Status: 🟢 Enrolling Now
Condition: Plasma Cell Myeloma Refractory
Phase: PHASE1

Where You Can Participate

This study is available at 13 locations across the country.

Top locations include:
  • • Hackensack, New Jersey
  • • Philadelphia, Pennsylvania
  • • Wollongong, New South Wales
  • • And 10 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma - Join Clinical Trial NCTNCT06630806

How to Join This Clinical Trial - NCTNCT06630806

Learn how to participate in this PHASE1 trial studying an investigational therapy for Plasma Cell Myeloma Refractory. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Plasma Cell Myeloma Refractory. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Plasma Cell Myeloma Refractory
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06630806 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 13 locations. Find a study site near you:

Clinical Research Site

Hackensack, New Jersey 07601 - United States

Status: RECRUITING

Clinical Research Site

Philadelphia, Pennsylvania 19107 - United States

Status: RECRUITING

Clinical Research Site

Wollongong, New South Wales 2500 - Australia

Status: RECRUITING

Clinical Research Site

Fitzroy, Victoria 3065 - Australia

Status: RECRUITING

Clinical Research Site

Montreal, Quebec H4A 3J1 - Canada

Status: RECRUITING

Clinical Research Site

Sherbrooke, Quebec J1H 5N4 - Canada

Status: RECRUITING

Clinical Research Site

Tel Aviv, Malopolskie 6423906 - Israel

Status: RECRUITING

Clinical Research Site

Haifa, 3109601 - Israel

Status: RECRUITING

Clinical Research Site

Jerusalem, 91120 - Israel

Status: RECRUITING

Clinical Research Site

Rozzano (MI), Milano 20089 - Italy

Status: RECRUITING

And 3 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Plasma Cell Myeloma Refractory:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships